Evoke Wealth’s Immunogen Inc IMGN Stock Holding History

Evoke Wealth’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,528	Closed	-$3.7K	–	1510
2019 Q3	$3.7K	Buy	+1,528	New	+$4.06K	﹤0.01%	1082

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Evoke Wealth's IMGN Position: Q4 2019 in Review

Evoke Wealth sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 1,528 shares — an estimated $3.7K sold.

Evoke Wealth first reported a position in IMGN in Q3 2019 and held it in 1 quarter. The position peaked at $3.7K in Q3 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

Evoke Wealth reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
Evoke Wealth sold 1,528 Immunogen Inc shares in Q4 2019, an estimated $3.7K.
Evoke Wealth first reported a position in Immunogen Inc in Q3 2019 and held it in 1 quarter.
Evoke Wealth's Immunogen Inc position peaked at $3.7K in Q3 2019.
191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.